Renal Cell Carcinoma (RCC)
Showing 1 - 25 of >10,000
Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)
Not yet recruiting
- Renal Cell Carcinoma
- Pembrolizumab injection
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 20, 2023
Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)
Recruiting
- Advanced Renal Cell Carcinoma
- ST-1898 tablets
-
Beijing, Beijing, ChinaPeking University Cancer Hospital & Institute
Nov 6, 2023
RCC, Renal Cell Carcinoma Trial in Dallas (Cabozantinib 80 MG, Cabozantinib 40Mg Tab, Nivolumab)
Not yet recruiting
- RCC
- Renal Cell Carcinoma
- Cabozantinib 80 MG
- +2 more
-
Dallas, TexasUT Southwestern Medical Center
Jul 3, 2023
Renal Cell Carcinoma Trial in Houston (Sunitinib, Nephrectomy)
Active, not recruiting
- Renal Cell Carcinoma
- Sunitinib
- Nephrectomy
-
Houston, Texas
- +1 more
Oct 11, 2022
Kidney Cancer Trial in Birmingham (Acarbose Tablets)
Not yet recruiting
- Kidney Cancer
- Acarbose Tablets
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 2, 2022
Renal Cell Carcinoma (RCC) Trial in Birmingham (Trans-arterial embolization (TAE))
Not yet recruiting
- Renal Cell Carcinoma (RCC)
- Trans-arterial embolization (TAE)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 5, 2022
Renal Cell Carcinoma Trial in Iowa City (Lenvatinib, Everolimus, Partial or Radical Cytoreductive Nephrectomy)
Recruiting
- Renal Cell Carcinoma
- Lenvatinib
- +2 more
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
May 4, 2022
Advanced Renal Cell Carcinoma Trial (QL1706 Plus Lenvatinib)
Not yet recruiting
- Advanced Renal Cell Carcinoma
- QL1706 Plus Lenvatinib
- (no location specified)
Feb 21, 2022
Renal Cell Carcinoma Trial in Houston (Perfusion CT scan)
Active, not recruiting
- Renal Cell Carcinoma
- Perfusion CT scan
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 6, 2022
Recurrent Renal Cell Carcinoma, Renal Cell Carcinoma Trial in Philadelphia (drug, procedure, other)
Recruiting
- Recurrent Renal Cell Carcinoma
- Renal Cell Carcinoma
- Sulfur Hexafluoride Lipid Microspheres
- +4 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Nov 29, 2022
Kidney Cancer Trial in Houston (Axitinib)
Active, not recruiting
- Kidney Cancer
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 2, 2022
Primary and Metastatic Tumors in Renal Cell Carcinoma and
Recruiting
- Renal Cell Carcinoma
- +4 more
- Immune checkpoint inhibitor targeting PD1
-
Philadelphia, PennsylvaniaFox Chase Cancer Center - Philadelphia
Jan 27, 2023
Melanoma, Hepatocellular Carcinoma (HCC), Renal Cell Carcinoma (RCC) Trial (INCB 99280 with Ipilimumab)
Not yet recruiting
- Melanoma
- +5 more
- INCB 99280 with Ipilimumab
- (no location specified)
Jun 9, 2023
Renal Cell Carcinoma (RCC) Trial in Heidelberg (Chimeric mAb cG250, Sunitinib malate)
Terminated
- Renal Cell Carcinoma (RCC)
- Chimeric monoclonal antibody cG250
- Sunitinib malate
-
Heidelberg, Victoria, AustraliaAustin Health (Ludwig Institute Oncology Unit)
Oct 3, 2022
Renal Cancer, Renal Cell Carcinoma, Renal Cell Cancer Metastatic Trial
Recruiting
- Renal Cancer
- +2 more
-
Amsterdam, Noord Holland, NetherlandsAmsterdam UMC locatie VUMC
Jan 20, 2023
Cancer of Kidney, Kidney Cancer, Renal Cancer Trial in New York (124-Iodine-cG250 (124I-cG250))
Completed
- Cancer of Kidney
- +6 more
- 124-Iodine-cG250 (124I-cG250)
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Oct 3, 2022
Implementation of Shared Decision Making Strategy for Renal Cell
Recruiting
- Renal Cell Carcinoma
- Renal Cell Carcinoma Metastatic
- Decision aid
-
Nieuwegein, Utrecht, NetherlandsSt. Antonius Ziekenhuis
Nov 28, 2022
Preferences of Participants and Oncologists for Characteristics
Completed
- Renal Cell Carcinoma
-
Castellon de La Plana, SpainLocal Institution
Dec 8, 2021
Observe Onset of Immune-related Adverse Reactions in
Completed
- Renal Cell Carcinoma
- Kidney Cancer
- Non-Interventional
-
Tokyo, JapanLocal Institution
Feb 9, 2022
Metastatic Renal Cell Carcinoma Trial in United Kingdom (Cyclophosphamide 50mg, Pembrolizumab 25 mg/1 ML Intravenous Solution
Recruiting
- Metastatic Renal Cell Carcinoma
- Cyclophosphamide 50mg
- Pembrolizumab 25 mg/1 ML Intravenous Solution [KEYTRUDA]
-
Cambridge, United Kingdom
- +3 more
Aug 22, 2022
Renal Cell Carcinoma Trial in United States (everolimus and bevacizumab)
Completed
- Renal Cell Carcinoma
- everolimus and bevacizumab
-
Basking Ridge, New Jersey
- +6 more
Jan 3, 2022
Advanced Renal Cell Carcinoma Trial in Heilbronn (IVAC)
Recruiting
- Advanced Renal Cell Carcinoma
- IVAC
-
Heilbronn, GermanySLK Kliniken Heilbronn, Klinik für Innere Medizin III: Hämatolog
Nov 30, 2022